US55234L1052 - Common Stock
LYRA THERAPEUTICS INC
NASDAQ:LYRA (5/17/2024, 7:11:46 PM)
After market: 0.3876 +0 (+1.2%)0.383
+0.02 (+4.19%)
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. The company is headquartered in Watertown, Massachusetts and currently employs 78 full-time employees. The company went IPO on 2020-05-01. The firm is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The firm has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are bioresorbable nasal implants designed to be administered in a brief, in-office procedure and are intended to deliver six months of continuous mometasone furoate drug therapy to the sinonasal passages. LYR-210 is designed for surgically naive patients and is being evaluated in the ENLIGHTEN Phase III clinical program, while LYR-220, an enlarged implant, is being evaluated in the BEACON Phase II clinical trial in patients who have recurrent symptoms despite having had prior ethmoid sinus surgery.
LYRA THERAPEUTICS INC
480 Arsenal Way
Watertown MASSACHUSETTS 02472
P: 16173734600
CEO: Maria Palasis
Employees: 78
Website: https://lyratherapeutics.com/
Unusual volume stocks in Wednesday's session
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
These stocks are moving in today's session
Stay updated with the stocks that are on the move in Tuesday's pre-market session.
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
Which stocks are moving on Monday?
Here you can normally see the latest stock twits on LYRA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: